← Human Trials & Peer-Reviewed Studies
Relation between vitamin D and impulse behaviours in patients with eating disorder: a pilot observational study.
Plain-language guide to PMID 32372472 (2020): pilot observational study of Vitamin D, K2, Magnesium and Zinc in 236 patients.
Key Facts
- PMID
- 32372472
- Journal
- European eating disorders review : the journal of the Eating Disorders Association
- Year
- 2020
- Study type
- Observational Study
- Authors
- Todisco P et al. (6 authors)
- DOI
- 10.1002/erv.2740
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as an observational study.
There is growing evidence that vitamin D levels have a role not only in bone health and energy metabolism, but also for supporting nervous system and brain functions, including impulsivity.
Impulsive behaviours are considered characteristics of great relevance in patients with Eating Disorders (ED) both for the course of the illness and for the treatment.
The aim of this study is to examine the relationship between impulsive behaviours and vitamin D in patients with ED.
Who Took Part
The abstract describes 236 patients taking part.
The age groups tagged for this paper are teenagers, young adults and adults, both men and women.
236 patients with a diagnosis of ED, consecutively recruited at an ED ward between 2014 and 2018, were enrolled.
Patients were classified as impulsive or non-impulsive based on the presence of clinically relevant impulsive behaviours.
How the Study Was Run
The researchers set it up as a pilot study.
It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.
What Was Measured
The subject headings attached to it are Feeding and Eating Disorders, Impulsive Behavior, Longitudinal Studies, Pilot Projects, Vitamin D and Vitamin D Deficiency.
Author keywords: impulsive behaviour and impulsivity psychopathology.
What This Means in Plain Language
The paper is a pilot study of Vitamin D, K2, Magnesium and Zinc in 236 patients.
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2020 (European eating disorders review : the journal of the Eating Disorders Association), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.